- Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models
[作者:Predina, JD; Judy, B; Aliperti, LA; Fridlender, ZG; Blouin, A; Kapoor, V; Laguna, B; Nakagawa, H; Rustgi, AK; Aguilar, L; Aguilar-Cordova, E; Albelda, SM; Singhal, S,期刊:Cancer gene therapy, 页码:871-883 , 文章类型: Article,,卷期:2011年18-12]
- Esophageal carcinoma is the most rapidly increasing tumor in the United States and has a dismal 15% 5-year survival. Immunotherapy has been proposed to improve patient outcomes; however, no immunocompetent esophageal car...
- Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice
[作者:Zhu, H; Li, Z; Mao, S; Ma, B; Zhou, S; Deng, L; Liu, T; Cui, D; Zhao, Y; He, J; Yi, C; Huang, Y,期刊:Cancer gene therapy, 页码:884-896 , 文章类型: Article,,卷期:2011年18-12]
- Soluble fms-like tyrosine kinase receptor (sFlt-1) is a soluble form of extramembrane part of vascular endothelial growth factor receptor-1 (VEGFR-1) that has antitumor effects. Bifidobacterium Infantis is a kind of non-...
- Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study
[作者:Schwarzenberger, P; Byrne, P; Gaumer, R; Norton, J; Harrison, L; Marrogi, A; Kolls, JK,期刊:Cancer gene therapy, 页码:906-912 , 文章类型: Article,,卷期:2011年18-12]
- Mesothelioma is an incurable cancer of the pleura with a life expectancy of less than 1 year. On the basis of in vivo efficacy seen with the herpes simplex virus type 1 thymidine kinase (HSVtk) suicide gene-modified PA1S...
|